Skip to main content
Clinical Trials/NCT04760041
NCT04760041
Completed
Not Applicable

Nebulized Midazolam vs. Oral Midazolam as a Sedative Premedication in Pediatric Anesthesia: A Randomized Comparative Study

Cairo University1 site in 1 country72 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Midazolam nebulized
Conditions
Preoperative Sedation
Sponsor
Cairo University
Enrollment
72
Locations
1
Primary Endpoint
Time required to reach a satisfactory level of sedation
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study is to be carried out to compare nebulized and oral midazolam in achievement of a satisfactory level of sedation, Ramsey Sedation Score (RSS) of 4, within 30 mins of midazolam administration in pediatrics.

Detailed Description

This study is to be carried out to compare nebulized midazolam and oral midazolam in achievement of a satisfactory level of sedation, Ramsey Sedation Score (RSS) of 4, within 30 mins of midazolam administration in pediatric surgical patients. In Pediatric Specialized Hospital, Cairo University 72 pediatric patients scheduled for undergoing general or uro-surgical operations under general anesthesia will be included in this double-blinded study. Patients will be randomly assigned into two equal groups, each group including 36 patients. In one group 36 children will receive nebulized midazolam 0.2 mg/kg in 3 ml normal saline plus 5 ml clear juice (orally) 30 min before undergoing general anesthesia. In the other group 36 children will receive oral midazolam 0.5 mg/kg in 5 ml clear juice plus nebulizer of 3 ml normal saline 30 min before undergoing GA. level of sedation will be compared between both groups

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
August 10, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sherif Mohamed Abd El Moneim Soaida, MD

Assistant professor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients from 2 to 6 years undergoing uro-surgery and general surgical procedures.
  • Duration of surgery 1-2 hours
  • Gender eligible for the study: both.
  • ASA I-II.

Exclusion Criteria

  • ASA III-IV
  • Patients with elevated levels of serum ALT, Creatinine.
  • Emergency surgeries.
  • Pre-existing neurologic disease.
  • Parent refusal.
  • History of allergy to midazolam.
  • Patients with atopy or a history of asthma.
  • Lengthy procedures of more than 2 hours

Arms & Interventions

nebulized midazolam group

36 children will receive nebulized midazolam 0.2 mg/kg in 3 ml normal saline plus 5 ml clear juice 30 min before undergoing general anesthesia

Intervention: Midazolam nebulized

oral midazolam group

36 children will receive oral midazolam 0.5 mg/kg in 5 ml clear juice plus nebulizer of 3 ml normal saline 30 min before undergoing anesthesia

Intervention: Midazolam oral solution

Outcomes

Primary Outcomes

Time required to reach a satisfactory level of sedation

Time Frame: from time of applying the nebulizer until 30 minutes

time to reach ramsay sedation score 4

Secondary Outcomes

  • Acceptability of method of administration of midazolam by a grading system(from time of giving midazolam oral or nebulized till 30 minutes)
  • changes in oxygen saturation(from start of sedation till 1 hour postoperative at 5 minute intervals)
  • changes in heart rate(from start of sedation till 1 hour postoperative at 5 minute intervals)
  • Recovery time(time from discontinuation of anesthesia until regaining baseline sedation score at 5 minute intervals)
  • Ease of separation from parents(from 30 minutes after receiving midazolam till transfer to operating room)
  • acceptability of Face mask by grading systen(from time of applying face mask till time of getting asleep at 1 minute intervals)
  • Changes in mean arterial blood pressure(from start of sedation till 1 hour postoperative at 5 minute intervals)

Study Sites (1)

Loading locations...

Similar Trials